share_log

SAB Biotherapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Sessa Capital (Master), L.P.

SAB Biotherapeutics | 4/A:持股变动声明(修正)-董事 Sessa Capital (Master), L.P.

美股sec公告 ·  2023/11/15 16:30
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息